Anti-aging medicine and research. A realm of conflict and profound societal implications

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 59, Issue 6, 2004, Pages 523-533

  Binstock, Robert H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI AGING AGENT; MINERAL WATER; NEW DRUG; UNCLASSIFIED DRUG;

AGING; ANTI AGING MEDICINE; GERIATRICS; GERONTOLOGICAL RESEARCH; HUMAN; INJECTION; LIFE; LIFE EXPECTANCY; LIFESPAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; REVIEW; SCIENCE; SOCIETY;

AGED; AGING; GERIATRICS; HISTORY, 20TH CENTURY; HISTORY, ANCIENT; HUMANS; LONGEVITY; RESEARCH; RESEARCH SUPPORT; SOCIAL CONTROL, INFORMAL; UNITED STATES;

EID: 3042834648     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Olshansky SJ, Hayflick L, Carnes BA. No truth to the fountain of youth. Sci Am. 2002;286:92-95.
2. Olshansky JS, Hayflick L, Carnes BA. The Truth About Human Aging. Retrieved January 12, 2004, from http://sciam.com/article.cfm? articlelD=0004F171-FE1E=1CDF-B4A8809EC588EEDF&catID=4.
3. Hayflick L, personal communication, July 18, 2002.
4. Olshansky JS, Hayflick L, Carnes, BA. Position Statement on Human Aging. Retrieved June 25, 2002, from http://scienceonline.org
5. Olshansky SJ, Hayflick L, Carnes, BA. Position statement on human aging. J Gerontol Biol Sci. 2002;57A:B292-B297.
6. Olshansky SJ, personal communication, July 18, 2002.
7. Pope E. 51 top scientists blast anti-aging idea. AARP Bull. 2002;23:3-5.
8. Miller RA. Extending life: scientific prospects and political obstacles. Milbank Q. 2002;80:155-174.
9. de Grey ADNJ, Ames BN, Andersen JK, et al. Time to talk SENS: critiquing the immutability of human aging. Ann N Y Acad Sci. 2002;959:452-462.
10. Lane MA, Ingram DK, Roth GS. The serious search for an anti-aging pill. Sci Am. 2002;287:36-41.
11. Gruman GJ. A history of ideas about the prolongation of life: the evolution of prolongevity hypotheses to 1800. Trans Am Philos Soc. 1966;56(Part 9). Philadelphia, PA.
12. Olshansky SJ, Carnes BA. The Quest for Immortality: Science at the Frontiers of Aging. New York: Norton; 2001.
13. International Longevity Center-USA. Is There an "Anti-Aging Medicine?" New York: Intemational Longevity Center-USA; 2001.
14. Butler RN. Is there an "anti-aging" medicine? Generations. 2001-2002;XXV:63-65.
15. Butler RN, Fossel M, Harman SM, et al. Is there an antiaging medicine? J Gerontol Biol Sci. 2002;57A:B333-B338.
16. U.S. Senate Special Committee on Aging. Swindlers, Hucksters and Snake Oil Salesmen: The Hype and Hope of Marketing Anti-Aging Products to Seniors. Hearing held in Washington, DC, September 10, 2001.
17. U.S. General Accounting Office. Health Productsfor Seniors: "Anti-Aging" Products Pose Potential for Physical and Economic Harm. Washington, DC: U.S. Government Printing Office, GAO-01-1129; 2001.
18. Wick G. "Anti-aging" medicine: does it exist? A critical discussion of "anti-aging" health products. Exp Gerontol. 2002, online prepublication, retrieved on September 16, 2002, from sciencedirect.com
19. Fischer A, Morley JE. Antiaging medicine: the good, the bad, and the ugly. J Gerontol Med Sci. 2002;57A:M636-M639.
20. National Institute on Aging. Life-extension. Science or sciencefiction? Retrieved on July 8, 2002, from http://www.nia.nih.gov/health/ agepages/lifeext.htm
21. National Institute on Aging. Looking for the Fountain of Youth? Retrieved July 3, 2002, from http://www.nia.nih.gov/health/ads/ fountl.git
22. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA. 2002;288:282-292.
23. Janssens H, Vanderschueren DMOI. Endocrinological aspects of aging in men: is hormone replacement of benefit? Eur J Obstet Gynecol Reprod Biol. 2000;92:7-12.
24. Chan JM, Stampfer MJ, Giovanucci E, et al. Plasma insulin-like growth factor I and prostate cancer risk: a prospective study. Science. 1998;279:563-566.
25. Shumaker SA, Legault C, Rapp SR, et al., for the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women-The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003;289:2651-2662.
26. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
27. Vance ML. Can growth hormone prevent aging? N Engl J Med. 2003;348:779-880.
28. Gieryn TF. Boundary-work and the demarcation of science from nonscience: strains and interests in professional ideologies of scientists. Am Socio Rev. 1983;48:781-795.
29. Taylor CA. Defining Science: A Rhetoric of Demarcation. Madison, WI: University of Wisconsin Press; 1996.
30. Lockett BA. Aging, Politics, and Research: Setting the Federal Agenda for Research on Aging. New York: Springer Publishing Company; 1983.
31. Achenbaum WA. Crossing Frontiers: Gerontology Emerges as a Science. New York: Cambridge University Press; 1995.
32. Hayflick L. How and Why We Age. New York: Ballantine Books; 1994.
33. Cowdry VE. Problems of Ageing: Biological and Medical Aspects. Baltimore, MD: Williams and Wilkins; 1939.
34. Adler M. History of Gerontological Society, Inc. J Gerontol. 1958;13:94-102.
35. Schutz CA, executive director, Gerontological Society of America, personal communication based on organizational records, June 19, 2002.
36. Current Comments. Grants for research on aging. Gerontologist. 1947;2:156.
37. Eisdorfer C. Patterns of federal funding for research in aging. Gerontologist. 1968;8(1, Part 1):3-6.
38. U.S. Senate Subcommittee on Aging of the Committee on Labor and Public Welfare. Research on Aging Act, 1973. Washington, DC: U.S. Government Printing Office; 1973.
39. Robinson J. Noble Conspirator: Florence S. Mahoney and the Rise of the National Institutes of Health. Washington, DC: The Francis Press; 2001.
40. The Research on Aging Act of 1974 Pub. L. No. 93-296.
41. Cozzens SE. Autonomy and power in science. In: SE Cozzens, TF Gieryn, eds. Theories of Science in Society. Bloomington, IN: Indiana University Press; 1990:164-184.
42. Cristofalo VJ, Adelman R, eds. Focus on Modern Topics in the Biology of Aging: Annual Review of Gerontology and Geriatrics, Vol. 21. New York: Springer Publishing Company; 2002.
43. Masoro EJ, Austad SN, eds. Handbook of the Biology of Aging. 5th Ed. San Diego, CA: Academic Press; 2001.
44. National Institute on Aging. National Institute on Aging: FY 2003 Budget. Retrieved July 17, 2002, from http://www.nia.nih.gov/ fy2003_congress/ justification.html
45. Haber C. Anti-aging: why now? a historical framework for understanding the contemporary enthusiasm. Generations. 2001-2002; XXV:9-14.
46. Pierpaoli W, Regelson W, Colman C. The Melatonin Miracle. New York: Simon and Schuster; 1995.
47. Fossel M. Reversing Human Aging. New York: William Morrow; 1996.
48. Carper J. Stop Aging Now!: The Ultimate Plan for Staying Young and Reversing the Aging Process. New York: HarperCollins Publishers; 1996.
49. Chopra D. Grow Younger, Live Longer: 10 Steps to Reverse Aging. New York: Harmony Books; 2001.
50. Shostak S. Becoming Immortal: Combining Cloning and Stem-cell Therapy. Albany, NY: State University of New York Press; 2002.
51. Cohn V, Mary Ann Liebert, Inc., which publishes the Journal of Anti-Aging Medicine, personal communication, July 17, 2002.
52. de Grey ADNJ, Gavrilov L, Olshansky SJ, et al. Antiaging technology and pseudoscience. Science. 2002;296:656.
53. Youngevity. (2003) The Youngevity Story. Retrieved May 24, 2003, from http://www.youngevity.com/the ygy_story_fs.htm
54. FIND/SVP. New anti-aging market creates opportunities for marketers. Retrieved September 9, 2003, from http://www.findsvp.com/ about/2003-04- 08antiaging.cfm
55. American Academy of Anti-Aging Medicine. Dying Branch of Medicine Displaced by Innovative Healthcare Model Generating $30 Billion/Year Global Revenue. Retrieved September 15, 2003, from http://www.worldhealth.net/ resources/Rel_032102.pdf
56. American Academy of Anti-Aging Medicine. Validating the Facts and Science of Anti-aging Medicine: Report on the State of the Clinical Specialty. A4M White Paper: The report of the Medical Committee on Aging Research and Care. Retrieved June 13, 2002, from http://www.worldheakh.net/whitepaper/index.htm
57. American Academy of Anti-Aging Medicine. About Anti-aging Medicine. Retrieved June 13, 2002, from http://www.worldhealth. net/ about_anti_aging_medicine.htm
58. Klatz R, ed. Ten Weeks to a Younger You. Chicago: Sport Tech Labs, Inc.; 1999.
59. Guidestar. Guidestar: The National Database for Nonprofit Organizations. Retrieved September 9, 2003 from http://documents. guidestar.org/1977/364/087/ 1997-364087310-1-9.pdf
60. Guidestar. Guidestar: The National Database for Nonprofit Organizations. Retrieved September 9, 2003 from http://documents. guidestar.org/2000364/087/ 2000-364087310-1-9.pdf
61. American Academy of Anti-Aging Medicine. Board Certification Programs. Retrieved June 13, 2002, from http://www.worldhealth.net/ whitepaper/id24.htm
62. American Academy of Anti-Aging Medicine. Achievements of the A4M. Retrieved June 13, 2002, from http://www.worldhealth.net/ whitepaper/id23.htm
63. Goldman B, Bush P, Klatz R. Death in the Locker Room: Steroids and Sports. South Bend, IN: Hardwood Press; 1984.
64. Goldman B, Klatz R. The "E" factor: Ergogenic Aids, the secrets of New-tech Training and Fitness for the Winning Edge. Chicago: Elite Sports Medicine Publications, Inc.; 1988.
65. Goldman B, Klatz R. 7 Anti-Aging Secrets. Chicago: Elite Sports Medicine Publications; 1996.
66. Klatz R, Goldman R. Stopping the Clock: Why Many of Us Will Live Past 100-and Enjoy Every Minute. New Canaan, CT: Keats Publishers; 1996.
67. Klatz R, Kahn C. Grow Young with HGH: The Amazing Medically Proven Plan to Reverse Aging. New York: Harper Perennial; 1998.
68. Klatz R, ed. Ten Weeks to a Younger You. Chicago: Sport Tech Labs, Inc.; 1999.
69. American Academy of Anti-Aging Medicine. Anti-Aging Products and Services: Anti-Aging Directory Listings. Retrieved November 3, 2003, from http://www.worldhealth.net/?p=54
70. Arumainathan S. Intellectual Dishonesty in Geriatric Medicine -Truth Versus Fallacy: A4M Sets the Record Straight on a Campaign of Disinformation Challenging the Facts of the Science of Anti-aging Medicine. Retrieved November 3, 2003, from http://www. worldhealth.net/resources/IntellDishonesty.PDF
71. Klatz R. Anti-aging medicine: resounding, independent support for expansion of an innovative medical specialty. Generations. 2001-2002;XXV:59-62.
72. American Academy of Anti-Aging Medicine. About A4M - History and Overview. Retrieved June 13, 2002, from http://www. worldhealth.net/html/ about_a4m history_and-over.htm
73. Holden C. The quest to reverse time's toll. Science. 2002;295:1032-1033.
74. American Academy of Anti-Aging Medicine. About Anti-aging Medicine. Retrieved June 13, 2002, from http://www.worldhealth. net/about_anti- aging_medicine.htm
75. Hayflick L. Anti-aging medicine: hype, hope, and reality. Generations. 2001-2002;XXV;20-26.
76. University of Illinois at Chicago. Silver Fleece Awards Target Anti-Aging Hype. Office of Public Affairs, News Release, February 12. Retrieved June 12, 2002, from http://tigger.uic.edu/htbin/cgiwmp/bin/ newsbureau
77. Nyberg J.P. The importance of aging research. ILC Policy Report. 2002; May: 1.
78. American Academy of Anti-Aging Medicine. (2002i) The fleecing of academic integrity by the gerontological establishment: American Academy of Anti-Aging Medicine official response statement to February 12, 2002 "Silver Fleece Awards Target Anti-Aging Hype" (University of Illinois News Release, February 12, 2002). February 22. Retrieved June 13, 2002, from http://www.worldhealth.net/html/ fleecing_of academic integrity.htm
79. American Academy of Anti-Aging Medicine. Official Position Statement on the Truth About Aging Intervention. Retrieved June 13, 2002, from http://www.worldhealth.net/html/truth/html
80. Donors Forum of Chicago-Philanthropic Database. Recipient: American Academy of Anti-Aging Medicine. Retrieved June 21, 2002, from http://homeless.cued.uic.edu/donors/forum
81. Cole TR, Thompson B, eds. Anti-aging: are you for it or against it? Generations. 2001-2002; XXV.
82. AARP Community Message Boards. Retrieved May 16, 2003, from http://community.aarp.org/n/mb/message.asp?webtage=rp-health&msg =45.1&maxT=7
83. Masoro EJ, ed. Caloric restriction's effects on aging: opportunities for research on human implications. J Gerontol Biol Med Sci. 2001:56A(Spec Iss I [March]).
84. Masoro EJ. Dietary restriction: an experimental approach to the study of the biology of aging. In: EJ Masoro, SN Austad, eds. Handbook of the Biology of Aging (5th Ed.). San Diego, CA: Academic Press; 2001:396-420.
85. Hadley EC, Dutta C, Finkelstein J, et al. Human implications of caloric restriction's effects on aging in laboratory animals: an overview of opportunities for research. J Gerontol Biol Med Sci. 2001:56A(Spec Iss 1):5-6.
86. Fries JF. Aging, natural death and the compression of morbidity. N Engl J Med. 1980;303:130-136.
87. Fries JF. An introduction to the compression of morbidity. Gerontologica perspecta. 1987;1:5-8.
88. de Grey ADNJ, Baynes JW, Berd D, Heward CB, Pawelec G, Stock G. Is human aging still mysterious enough to be left only to scientists? BioEssays. 2002;24:667-676.
89. de Grey ADNJ. Gerontologists and the media: the dangers of over-pessimism. Biogerontology. 2002;1:369.
90. de Grey, ADNJ personal communication, October 15, 2002.
91. Bonnicksen AL. Crafting a Cloning Policy: From Dolly to Stem Cells. Washington, DC: Georgetown University Press; 2002.
92. Harris J. Intimations of immortality. Science. 2002;288:59.
93. Harris J, Hom S. Extending human lifespan and the precautionary paradox. J Med Philos. 2002;27:355-368.
94. Fossel M. Reversing Human Aging. New York: William Morrow; 1996.
95. Kass LR. L'chaim and its limits: why not immortality? First Things. 2001;13:17-24.
96. Kass LR. Toward a More Natural Science: Biology and Human Affairs. New York: The Free Press; 1985.
97. President's Council on Bioethics. Beyond Therapy: Biotechnology and the Pursuit of Happiness. New York: Harper Collins Publishers; 2003.
98. Callahan D. Setting Limits: Medical Goals in an Aging Society. New York: Simon and Schuster; 1987.
99. Callahan D. Death and the research imperative. N Engl J Med. 2000;342:654-656.
100. Callahan D. A new debate on an old topic. Hastings Ctr Rep. 2003;33:3.
101. Shay JW, Wright WE, Hayflick, his limit, and cellular ageing. Perspectives. 2000;1:72-76.
102. Hayflick L. The future of aging. Nature. 2000;408:267-269.
103. de Grey ADNJ. The foreseeability of real anti-aging medicine: focusing the debate. Exp Gerontol. 2003;38:927-934.
104. Hall SS. Merchants of Immortality: Chasing the Dream of Human Life Extension. Boston: Houghton Mifflin Co.; 2003.
105. Binstock RH. The prolonged old, the long-lived society, and the politics of age. In: SG Post, RH Binstock, eds. The Fountain of Youth: Cultural, Scientific, and Ethical Perspectives on a Biomedical Goal. New York; Oxford University Press. In Press.
106. Seltzer M, ed. The Impact of Increased Life Expectancy: Beyond the Gray Horizon. New York: Springer Publishing Co.; 1995.
107. Hackler C. Troubling implications of doubling the human lifespan, Generations. 2001-2002;25:15-19.
108. Post SG, Binstock RH. The Fountain of Youth: Cultural, Scientific, and Ethical Perspectives on a Biomedical Goal. New York: Oxford University Press; 2004.
109. Adelman RC. The Alzheimerization of aging. Gerontologist. 1995;13:526-532.
110. Estes CL, Binney EA. The biomedicalization of aging: dangers and dilemmas. Gerontologist. 1989;29:587-596.